20 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... screen within 1 ... 0.5mL IM at 0, 1– ... HumanPapillomavirus #IDSA ... #Prevention #Treatment
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... Epidemiology: • #1 ... post-ABx, but can be community-acquired ... Ileus, Megacolon, Shock ... 10 mg/kg IV x 1
Common Infections in Solid-Organ Transplant Recipients
< 1 Month
 - Infection with antimicrobial-resistant species
 - Donor-derived infection
Common Infections ... Recipients < 1 ... colonization) 1- ... antiviral (CMV,HBV ... > 6 Months - Community-acquired
Common Variable Immunodeficiency (CVID)

What?
CVID: Immunodeficiency disorder with hypogammaglobulinemia -> increased infection risk secondary to impaired B-cell
• Affects 1:25,000 ... and 1:50,000 patients ... frequent and severe community-acquired ... infections: Pneumonia ... Epstein-Barr syndrome, HIV
Algorithm for the Evaluation of Acute Diarrhea (< 7 days)
Are the following present?
   1.
1. ... following: 1. ... Community water-borne ... HIV infection or ... Hospitalization required
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... 4–6 mL QID or 1– ... antifungals are required ... opportunistic #infections
Treating Condyloma Acuminatum (Genital Warts) - IDSA
Patients with HIV may have larger or more numerous warts,
Genital Warts) - IDSA ... option maybe required ... ; repeat every 1– ... Genital #Warts #idsa ... #hpv
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... • Valacyclovir 1 ... • Valacyclovir 1 ... • Continue treatment ... #IDSA #Prevention
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... Leishmaniasis in HIV-AIDS ... mg/kg on days 1– ... Leishmaniasis #Prevention #Treatment ... opportunistic #infections
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... in HIV-AIDS Preventing ... ) for 1–4 doses ... control of the infection ... Cytomegalovirus #CMV #IDSA